Michael Klayko, Director at ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX), bought 4,000 shares at $12.52 ($50K) on 2014-06-13, disclosed to the SEC on 2018-06-14.
Open-market purchase of $50k MDRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CONE | SELL | 2020-05-08 | $812K | — | Filing → |
| CONE | BUY | 2019-03-11 | $200K | — | Filing → |
| PMCS | SELL | 2015-12-07 | $532K | — | Filing → |